US and European VC-backed oncology biopharma company M&A values 2010-2019
In 2019, the transaction volumes of private non-oncology biopharma companies reached 12.2 billion U.S. dollars, whereas the values for oncology companies were at 4.1 billion U.S. dollars. This statistic shows the M&A transaction volumes of private venture capital-backed oncology vs. non-oncology biopharma companies in U.S. and Europe from 2010 to 2019.